Nu-Med Plus (NUMD) Depreciation and Depletion (2012 - 2022)

Nu-Med Plus has disclosed Depreciation and Depletion across 11 years of filings, most recently posting $1.0 for Q4 2022.

• Depreciation and Depletion for Q4 2022 came in at $1.0, down 99.96% year-over-year; the trailing twelve-month figure through Dec 2022 was $2267.0 (down 75.79% YoY), and the FY2022 annual result was $2267.0, down 75.79% from the prior year.
• Depreciation and Depletion came in at $1.0 for Q4 2022 at Nu-Med Plus, down from $34.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $3803.0 in Q2 2018 to a low of $1.0 in Q4 2022.
• The 5-year median for Depreciation and Depletion is $3042.0 (2019), against an average of $2576.7.
• Across the five-year window, Depreciation and Depletion surged 100.62% in 2018 and sank 99.96% in 2022, its largest moves.
• Nu-Med Plus' Depreciation and Depletion stood at $3774.0 in 2018, then retreated by 19.55% to $3036.0 in 2019, then decreased by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021, then tumbled by 99.96% to $1.0 in 2022.
• The last three Depreciation and Depletion figures came in at $1.0 (Q4 2022), $34.0 (Q3 2022), and $217.0 (Q2 2022), per Business Quant data.